Abstract The French Society of Anesthesia and Intensive Care Medicine and the French
Society of Intensive Care edited guidelines focused on hospital-acquired pneumonia (HAP) …

Introduction Many controversies still remain in the management of hospital acquired
pneumonia (HAP), and ventilation-acquired pneumonia (VAP), Three European Societies …

Pneumonia complicates hospitalization in 0.5 to 2.0% of patients and is associated with
considerable morbidity and mortality. Risk factors for hospital-acquired pneumonia (HAP) …

In accordance with the recommendations of, amongst others, the Surviving Sepsis
Campaign and the recently published European treatment guidelines for hospital-acquired …

Microbial cause of ICU-acquired pneumonia: hospital-acquired... : Current Opinion in Critical
Care Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus …

Hospital-acquired pneumonia (HAP) is one of the most common causes of nosocomial
infection, morbidity, and mortality in hospitalized patients. Many patient-and disease-specific …

BACKGROUND Nosocomial pneumonia (NP) is the second most common cause of
nosocomial infections. 1 NP is defined as lower respiratory infection that develops in a …

Due to the increasing prevalence of HAP/VAP caused by MDR Gram-negative pathogens,
management should be guided by the local ecology and the patient's risk factors for MDR …

Background While current guidelines recommend consideration of local microbiologic data
when selecting empiric treatment for hospital-acquired pneumonia (HAP), few specifics of …

Background Hospital-acquired pneumonia (HAP) is one of the leading nosocomial
infections and is associated with high morbidity and mortality. Numerous studies on HAP …